Cite
HARVARD Citation
Booth, L. et al. (2019). Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells. Cancer biology & therapy. 20 (5), pp. 700-710. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Booth, L. et al. (2019). Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells. Cancer biology & therapy. 20 (5), pp. 700-710. [Online].